- Home
- ELTX vs GNTA Comparison
ELTX vs GNTA Comparison
Compare ELTX & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- GNTA
- Stock Information
- Founded
- ELTX 2011
- GNTA 2014
- Country
- ELTX United States
- GNTA Italy
- Employees
- ELTX N/A
- GNTA N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELTX Health Care
- GNTA Health Care
- Exchange
- ELTX Nasdaq
- GNTA Nasdaq
- Market Cap
- ELTX 49.7M
- GNTA 67.4M
- IPO Year
- ELTX 2021
- GNTA 2021
- Fundamental
- Price
- ELTX $4.16
- GNTA $5.34
- Analyst Decision
- ELTX Buy
- GNTA Strong Buy
- Analyst Count
- ELTX 2
- GNTA 1
- Target Price
- ELTX $10.00
- GNTA $25.00
- AVG Volume (30 Days)
- ELTX 16.1K
- GNTA 28.4K
- Earning Date
- ELTX 11-07-2024
- GNTA 01-01-0001
- Dividend Yield
- ELTX N/A
- GNTA N/A
- EPS Growth
- ELTX N/A
- GNTA N/A
- EPS
- ELTX N/A
- GNTA N/A
- Revenue
- ELTX N/A
- GNTA N/A
- Revenue This Year
- ELTX N/A
- GNTA N/A
- Revenue Next Year
- ELTX N/A
- GNTA N/A
- P/E Ratio
- ELTX N/A
- GNTA N/A
- Revenue Growth
- ELTX N/A
- GNTA N/A
- 52 Week Low
- ELTX $2.96
- GNTA $2.20
- 52 Week High
- ELTX $11.45
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- ELTX 40.82
- GNTA 56.89
- Support Level
- ELTX $4.05
- GNTA $4.89
- Resistance Level
- ELTX $4.89
- GNTA $6.20
- Average True Range (ATR)
- ELTX 0.28
- GNTA 0.70
- MACD
- ELTX -0.06
- GNTA -0.06
- Stochastic Oscillator
- ELTX 27.37
- GNTA 37.32
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.